CDER New May 15, 2015

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

May 14, 2015


New and Generic Drug Approvals

May 13, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Akynzeo netupitant; palonosetron hydrochloride Capsule;Oral Helsinn Hlthcare Labeling Revision
Aloprim allopurinol sodium Injectable;Injection Mylan Institutional Manufacturing Change or Addition
Drospirenone; Ethinyl Estradiol; Levomefolate Calcium; Levomefolate Calcium drospirenone;ethinyl estradiol;levomefolate calcium;levomefolate calcium Tablet;Oral Watson Labs Inc Tentative Approval
Lamivudine and Zidovudine lamivudine and zidovudine Tablet; Oral Strides Arcolab Ltd Approval
Lamivudine and Zidovudine lamivudine; zidovudine Tablet;Oral Strides Arcolab Ltd Approval
Pegintron peginterferon alfa-2b Syringe Schering Labeling Revision
Pegintron peginterferon alfa-2b Vial Schering Labeling Revision
Sodium Chloride 0.9% In Plastic Container sodium chloride Injectable;Injection Baxter Hlthcare Manufacturing Change or Addition
Stendra avanafil Tablet;Oral Vivus Labeling Revision
Sylatron peginterferon alfa-2b Vial Schering Labeling Revision
Venofer iron sucrose Injectable;Intravenous Luitpold Manufacturing Change or Addition

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New May 15, 2015"

Post a Comment